We are live on
!
Find out more
SCM
Sitrin Capital Management Portfolio holdings
AUM
$200M
1-Year Est. Return
28.77%
This Fund
S&P 500
This Quarter
Est. Return
+1.85%
1 Year Est. Return
+28.77%
3 Year Est. Return
+96.96%
5 Year Est. Return
+115.7%
10 Year Est. Return
+651.97%
AUM
$126M
AUM Growth
+$11.6M
(+10%)
Cap. Flow
+$3.16M
Cap. Flow
% of AUM
2.52%
Top 10 Holdings %
Top 10 Hldgs %
42.47%
Holding
39
New
2
Increased
2
Reduced
26
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arthur J. Gallagher & Co
AJG
|
+$8.61M |
| 2 |
Accenture
ACN
|
+$3.45M |
| 3 |
Apple
AAPL
|
+$1.23M |
| 4 |
Walt Disney
DIS
|
+$262K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$3.62M |
| 2 |
Morgan Stanley
MS
|
+$2.86M |
| 3 |
Meta Platforms (Facebook)
META
|
+$208K |
| 4 |
Starbucks
SBUX
|
+$204K |
| 5 |
Home Depot
HD
|
+$188K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.99% |
| 2 | Technology | 16.57% |
| 3 | Consumer Discretionary | 13.94% |
| 4 | Healthcare | 11.37% |
| 5 | Consumer Staples | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
MetLife
MET
$61.9B
| $3.23M | 2.57% |
82,599
-3,332
| -4% | -$125K |
|
27
Goldman Sachs
GS
$300B
| $3.08M | 2.45% |
19,619
-632
| -3% | -$97.7K |
|
28
Alphabet (Google) Class A
GOOGL
$4.36T
| $2.69M | 2.14% |
70,500
-2,880
| -4% | -$106K |
|
|
29
Alphabet (Google) Class C
GOOG
$4.36T
| $2.61M | 2.07% |
70,000
-2,900
| -4% | -$104K |
|
30
SPDR Gold Trust
GLD
$131B
| $829K | 0.66% |
7,050
| – | – |
|
31
iShares Core S&P US Value ETF
IUSV
$27.2B
| $577K | 0.46% |
13,446
| – | – |
|
32
Invesco CurrencyShares Swiss Franc Trust
FXF
$414M
| $401K | 0.32% |
4,000
| – | – |
|
33
ExxonMobil
XOM
$644B
| $275K | 0.22% |
3,294
| – | – |
|
|
34
Walt Disney
DIS
$167B
| $270K | 0.21% |
+2,716
| New | +$262K |
|
35
AbbVie
ABBV
$443B
| $225K | 0.18% |
3,932
| – | – |
|
|
TWX
36
DELISTED
Time Warner Inc
TWX
| $207K | 0.16% |
2,860
| – | – |
|
37
Corcept Therapeutics
CORT
$12.4B
| $187K | 0.15% |
40,000
| – | – |
|
|
38
Biogen
BIIB
$30B
| – | – |
-12,874
| Closed | -$3.62M |
|
|
39
Morgan Stanley
MS
$331B
| – | – |
-99,687
| Closed | -$2.86M |
|
Similar funds
FU
FA
BMA
SF
FWM
TCM
SPI
LC
Sitrin Capital Management's Q1 2016 Portfolio in Review
As of Q1 2016, Sitrin Capital Management held 39 positions worth $126M, up 10% from $114M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Sitrin Capital Management's Q1 2016 filing shows 2 new, 2 increased, 26 reduced and 2 closed positions. Its largest new stake was Accenture: 33,560 shares worth $3.87M. The largest sale was Biogen, an estimated $3.62M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
- Sitrin Capital Management's largest Q1 2016 buy was Accenture: 33,560 shares worth $3.87M.
- Sitrin Capital Management added most to Arthur J. Gallagher & Co in Q1 2016, an estimated $8.61M increase.
- Sitrin Capital Management's biggest Q1 2016 reduction was Meta Platforms (Facebook), cutting an estimated $208K.
- Sitrin Capital Management fully exited Biogen in Q1 2016, selling an estimated $3.62M.
- Sitrin Capital Management's ten largest holdings make up 42% of its $126M portfolio in Q1 2016.
- Sitrin Capital Management opened 2 new positions and closed 2 in Q1 2016.
- Sitrin Capital Management's portfolio value rose 10% quarter-over-quarter to $126M.
Based on Sitrin Capital Management's 13F filing for Q1 2016, filed 11 May 2016.